{"id":"W4405309932","doi":"10.1111/bjh.19951","title":"Acalabrutinib in combination with rituximab and lenalidomide in patients with relapsed or refractory follicular lymphoma: Results of the phase 1b open‐label study ( <scp>ACE</scp> ‐ <scp>LY</scp> ‐003)","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Lenalidomide; Rituximab; Follicular lymphoma; Medicine; Open label; Refractory (planetary science); Oncology; Internal medicine; Lymphoma; Phases of clinical research; Pharmacology; Multiple myeloma; Chemotherapy; Clinical trial; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001793031,0.0008126574,0.001561054,0.0003881186,0.0002433423,0.0008205029,0.0006006606,0.000699935,0.001019084],"category_scores_gemma":[0.001014455,0.0003866964,0.001329275,0.0003828284,0.0004673882,0.0005955671,0.0002163818,0.001762582,0.0003104856],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008796469,"about_ca_system_score_gemma":0.000986424,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001542668,"about_ca_topic_score_gemma":0.004167346,"domain_scores_codex":[0.9994017,0.0003400365,0.00004553892,0.00006609069,0.00007268297,0.0000740062],"domain_scores_gemma":[0.9994247,0.0001219253,0.0001385762,0.00003537344,0.00004786003,0.0002315767],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4857632,0.04741648,0.04137015,0.00181377,0.007499909,0.0008085384,0.0007203353,0.004628893,0.07494491,0.0003150479,0.008596166,0.3261227],"study_design_scores_gemma":[0.4154598,0.4631391,0.09685159,0.0001538523,0.003402772,0.00109723,0.0002475237,0.004184343,0.005789699,0.0003487475,0.009243014,0.00008221827],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9896578,0.007621173,0.0002167151,0.0003556701,0.00007361528,0.0004233119,0.0004048623,0.00004642494,0.00120028],"genre_scores_gemma":[0.9940267,0.002959045,0.0005496196,0.0005428492,0.000172324,0.0002852812,0.0007833484,0.00001314599,0.0006677044],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001793031,"threshold_uncertainty_score":0.009482563,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02246386859953324,"score_gpt":0.3153559056079925,"score_spread":0.2928920370084593,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}